360 related articles for article (PubMed ID: 29018983)
1. Nutritional habits, risk, and progression of Parkinson disease.
Erro R; Brigo F; Tamburin S; Zamboni M; Antonini A; Tinazzi M
J Neurol; 2018 Jan; 265(1):12-23. PubMed ID: 29018983
[TBL] [Abstract][Full Text] [Related]
2. The Gut and Nonmotor Symptoms in Parkinson's Disease.
Klingelhoefer L; Reichmann H
Int Rev Neurobiol; 2017; 134():787-809. PubMed ID: 28805583
[TBL] [Abstract][Full Text] [Related]
3. Can the gut be the missing piece in uncovering PD pathogenesis?
Chapelet G; Leclair-Visonneau L; Clairembault T; Neunlist M; Derkinderen P
Parkinsonism Relat Disord; 2019 Feb; 59():26-31. PubMed ID: 30448099
[TBL] [Abstract][Full Text] [Related]
4. Brain-gut-microbiota axis in Parkinson's disease.
Mulak A; Bonaz B
World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
[TBL] [Abstract][Full Text] [Related]
5. The gut-brain axis in Parkinson's disease: Possibilities for food-based therapies.
Perez-Pardo P; Kliest T; Dodiya HB; Broersen LM; Garssen J; Keshavarzian A; Kraneveld AD
Eur J Pharmacol; 2017 Dec; 817():86-95. PubMed ID: 28549787
[TBL] [Abstract][Full Text] [Related]
6. Nutritional Risk Factors, Microbiota and Parkinson's Disease: What Is the Current Evidence?
Boulos C; Yaghi N; El Hayeck R; Heraoui GN; Fakhoury-Sayegh N
Nutrients; 2019 Aug; 11(8):. PubMed ID: 31416163
[TBL] [Abstract][Full Text] [Related]
7. Linking Smoking, Coffee, Urate, and Parkinson's Disease - A Role for Gut Microbiota?
Scheperjans F; Pekkonen E; Kaakkola S; Auvinen P
J Parkinsons Dis; 2015; 5(2):255-62. PubMed ID: 25882059
[TBL] [Abstract][Full Text] [Related]
8. The gut-brain axis and gut inflammation in Parkinson's disease: stopping neurodegeneration at the toll gate.
Gorecki AM; Dunlop SA; Rodger J; Anderton RS
Expert Opin Ther Targets; 2020 Jul; 24(7):601-604. PubMed ID: 32349553
[No Abstract] [Full Text] [Related]
9. Intestinal dysfunction in Parkinson's disease: Lessons learned from translational studies and experimental models.
Pellegrini C; Colucci R; Antonioli L; Barocelli E; Ballabeni V; Bernardini N; Blandizzi C; de Jonge WJ; Fornai M
Neurogastroenterol Motil; 2016 Dec; 28(12):1781-1791. PubMed ID: 27611012
[TBL] [Abstract][Full Text] [Related]
10. Prebiotic effects: metabolic and health benefits.
Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
[TBL] [Abstract][Full Text] [Related]
11. Feeding the microbiota: transducer of nutrient signals for the host.
Shanahan F; van Sinderen D; O'Toole PW; Stanton C
Gut; 2017 Sep; 66(9):1709-1717. PubMed ID: 28663354
[TBL] [Abstract][Full Text] [Related]
12. Structural changes of gut microbiota in Parkinson's disease and its correlation with clinical features.
Li W; Wu X; Hu X; Wang T; Liang S; Duan Y; Jin F; Qin B
Sci China Life Sci; 2017 Nov; 60(11):1223-1233. PubMed ID: 28536926
[TBL] [Abstract][Full Text] [Related]
13. Genes, emotions and gut microbiota: The next frontier for the gastroenterologist.
Panduro A; Rivera-Iñiguez I; Sepulveda-Villegas M; Roman S
World J Gastroenterol; 2017 May; 23(17):3030-3042. PubMed ID: 28533660
[TBL] [Abstract][Full Text] [Related]
14. Gut-liver axis, nutrition, and non-alcoholic fatty liver disease.
Kirpich IA; Marsano LS; McClain CJ
Clin Biochem; 2015 Sep; 48(13-14):923-30. PubMed ID: 26151226
[TBL] [Abstract][Full Text] [Related]
15. Potential role of gut microbiota and tissue barriers in Parkinson's disease and amyotrophic lateral sclerosis.
Fang X
Int J Neurosci; 2016 Sep; 126(9):771-6. PubMed ID: 26381230
[TBL] [Abstract][Full Text] [Related]
16. Dietary patterns and risk of Parkinson's disease: a case-control study in Japan.
Okubo H; Miyake Y; Sasaki S; Murakami K; Tanaka K; Fukushima W; Kiyohara C; Tsuboi Y; Yamada T; Oeda T; Shimada H; Kawamura N; Sakae N; Fukuyama H; Hirota Y; Nagai M;
Eur J Neurol; 2012 May; 19(5):681-8. PubMed ID: 22136555
[TBL] [Abstract][Full Text] [Related]
17. Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms.
Felice VD; Quigley EM; Sullivan AM; O'Keeffe GW; O'Mahony SM
Parkinsonism Relat Disord; 2016 Jun; 27():1-8. PubMed ID: 27013171
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota, 1013 new pieces in the Parkinson's disease puzzle.
Scheperjans F
Curr Opin Neurol; 2016 Dec; 29(6):773-780. PubMed ID: 27653288
[TBL] [Abstract][Full Text] [Related]
19. Collateral Damage: Contribution of Peripheral Inflammation to Neurodegenerative Diseases.
Herrera AJ; Espinosa-Oliva AM; Oliva-Martin MJ; Carrillo-Jimenez A; Venero JL; de Pablos RM
Curr Top Med Chem; 2015; 15(21):2193-210. PubMed ID: 26059357
[TBL] [Abstract][Full Text] [Related]
20. Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls.
Unger MM; Spiegel J; Dillmann KU; Grundmann D; Philippeit H; Bürmann J; Faßbender K; Schwiertz A; Schäfer KH
Parkinsonism Relat Disord; 2016 Nov; 32():66-72. PubMed ID: 27591074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
